
Distinguished Fellows of the American College of Medical Toxicology (DFACMT)
Quick Info:
Application Deadline for 2026 Cohort:
September 1st, 2025
Announcement and Recognition
Applicants will be notified of their status in late 2025. DFACMT inductees will be recognized at the ACMT Annual Scientific Meeting in Boston in March of 2026. It is expected that inductees will attend the live meeting for the induction ceremony.
Questions?
Contact membership@acmt.net
Distinguished Fellows of the College (DFACMT)
The DFACMT designation recognizes Fellows of the College who have demonstrated exceptional contributions to medical toxicology and distinguished service to the American College of Medical Toxicology (ACMT). This esteemed membership affiliation signifies a higher threshold of achievement beyond the criteria for FACMT.
Candidates for DFACMT are evaluated by the Membership Committee based on their exemplary involvement in the field of medical toxicology and their exceptional service to ACMT. Upon meeting these elevated standards, the Membership Committee recommends qualified candidates to the Board of Directors for approval.
This distinguished category provides recognition to those who surpass the rigorous standards of fellowship and reflect the highest ideals of the College.
- Applicants must be a current active Full, International, or Emeritus ACMT member in good standing and have held the FACMT designation for at least 10 years.
- Candidates for DFACMT must meet 1 of the following Service to the College criteria:
- Have served as a member of the ACMT Board of Directors for a minimum of 3 years (1 term)
- Lead or co-lead organizer for the ACMT Annual Scientific Meeting or equivalent ACMT course
- Served as Chair or an active member of an ACMT committee or section for at least 3 years, with a demonstrated record of substantial contributions—such as leading a key initiative, driving impactful projects, or significantly advancing the committee’s work or mission.
Candidates for DFACMT must meet 3 out of the 5 of the following criteria:
- Education
- Speaker at 3 or more National or International Toxicology Conferences or ACMT Board Review Courses
- Formal teaching of medical toxicology to healthcare professionals for a minimum of 8 years in one of the following roles: fellowship director, assistant fellowship director, residency rotation director, medical student rotation director, and or other major teaching responsibility
- Research
- Editorial board member of JMT for a minimum of 3 years
- Author on at least 10 reports of original research (not counting case reports or textbook chapters)
- Lead author or senior author on at least 5 reports of original research in medical toxicology (not counting case reports or textbook chapters)
- Clinical Practice
- Position of Medical Toxicology Section or Division Chief for at least 6 years
- Leadership role in the hospital including serving on the Pharmaceutical and Therapeutics committee, patient safety committee, IRB, peer review (QI) committee
- Public Service
- Role of Poison Center Medical Director or Assistant Medical Director for at least 8 years
- Government or public committee role addressing medical toxicology for at least 6 years
- Significant volunteerism
- Other
- Completed one term as an officer or board member of another professional organization
- Other activities or high honors that distinguish the physician as preeminent in the field of medical toxicology
The application process for DFACMT does not require a nomination and is initiated by the member. Steps include:
- Submit Application: Complete the application by the posted deadline.
- Provide Documentation: Detail contributions that demonstrate exceptional service to the College and other areas of distinction.
- Letters of Recommendation: Submit two letters of recommendation from ACMT members. At least one letter from a current FACMT member is encouraged but not required. Letters should be emailed to membership@acmt.net.
- Committee Review: Applications will be reviewed by the Membership Committee. Approval requires a two-thirds majority vote of the Committee members present.
- Board Approval: Upon Committee recommendation, the Board of Directors will review and provide final approval.